Mindset Financial Statements From 2010 to 2025
| MSSTFDelisted Stock | USD 0.36 0.00 0.00% |
Check Mindset Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mindset Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Mindset financial statements analysis is a perfect complement when working with Mindset Pharma Valuation or Volatility modules.
Mindset |
Mindset Pharma OTC Stock Return On Asset Analysis
Mindset Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Mindset Pharma Return On Asset | -0.48 |
Most of Mindset Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mindset Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Mindset Pharma has a Return On Asset of -0.4794. This is 94.52% lower than that of the Healthcare sector and 97.97% lower than that of the Biotechnology industry. The return on asset for all United States stocks is notably higher than that of the company.
Mindset Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mindset Pharma's current stock value. Our valuation model uses many indicators to compare Mindset Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mindset Pharma competition to find correlations between indicators driving Mindset Pharma's intrinsic value. More Info.Mindset Pharma is rated below average in return on equity category among its peers. It is regarded third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mindset Pharma's earnings, one of the primary drivers of an investment's value.About Mindset Pharma Financial Statements
Mindset Pharma stakeholders use historical fundamental indicators, such as Mindset Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Mindset Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Mindset Pharma's assets and liabilities are reflected in the revenues and expenses on Mindset Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Mindset Pharma. Please read more on our technical analysis and fundamental analysis pages.
Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. The company was founded in 2019 and is based in Toronto, Canada. Mindset Pharma is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Consideration for investing in Mindset OTC Stock
If you are still planning to invest in Mindset Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mindset Pharma's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |